Back
Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome.
Journal article

Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome.

  • Weber P Division of Neuropediatrics and Developmental Medicine, University Children's Hospital Basel, Basel, Switzerland. Peter.Weber@ukbb.ch
  • 2009-07-17
Published in:
  • Journal of child neurology. - 2010
Angelman Syndrome
Anticonvulsants
Brain
Child
Electroencephalography
Humans
Levetiracetam
Male
Piracetam
Status Epilepticus
Treatment Outcome
English Children with Angelman syndrome have an increased risk of developing a nonconvulsive status epilepticus. Although the urgency to treat nonconvulsive status epilepticus depends on the underlying illness, most clinicians and authors agree that treatment should be focused to rapidly terminate this condition. Until now, the use of levetiracetam to treat nonconvulsive status epilepticus in children is based only on some case reports. Our case further supports this treatment regime for a subgroup of children with a special risk of nonconvulsive status epilepticus and developmental delay.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/92731
Statistics
Document views: 21 File downloads: